Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 1,391–1,400 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 1391
- Medicine slug
- sertraline
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 163
- Source count
- 163
- Agreement rate
- 1
- Recorded readings
26 hours
- Numeric value
- 26
- Unit
- hours
- Source records
- 163
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 163 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a6d0f35c-f4f4-456d-b8d9-d56297261ad6 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ddfd698-3d47-fc0e-e063-6394a90accec (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4cf8d5c8-842b-4e7c-9a99-3f41ef8abbdb (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fd92c8d3-17ec-477c-bc25-e5239c8606ac (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ad69cbfe-5b42-4714-a999-77d474e0849d (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de1f85ac-df1b-4b7b-8e18-48ebdc8b9279 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af2c75a3-131e-4bde-83fd-310fd2c01161 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:626a9271-a268-4194-935d-779377f902f5 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5c6c817e-a555-4f55-837d-94458787fcb6 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1766ea8b-bb88-8bb8-e063-6394a90a032d (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9bcef7ef-4e2f-4ab9-9c0f-f4956bfdd71b (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ac8a624-2292-b7b8-e063-6394a90a165b (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4f6f2412-8085-45bf-be4f-63e44490a34e (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0e5a7b02-3972-47f0-9f49-e958d792beac (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:10b9cae4-b452-4abb-866a-9f9d2568f212 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7d598f1a-6c76-458a-a155-7a6a0743a2d3 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:664d1744-7b1d-43e2-98ba-1b0e69d75840 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:10baaffd-061e-d665-e063-6294a90a1594 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1fcd3f6d-a71f-b131-e063-6394a90a4b26 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7b5c29ff-25c8-4b68-844d-b8e95be7d09b (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:056191ca-999a-4c9b-93b9-64db44b8e628 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:345271ff-6a48-4888-a8d0-5a8ad60c7a21 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:82a44e20-d0ee-4ed7-9234-24ef4496ac1d (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ba201164-f6f7-4779-87a3-62780f332113 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:787a683a-091c-4908-a643-ecbc8fd467eb (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f5bf9595-d9f9-40b1-9b3b-da277fd5ab7f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9f1d5689-3bf1-431c-9ea2-9e37217ecf40 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ce05049-030f-3e8b-e063-6394a90a4885 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a58062b-e635-431a-908d-2651c6a4a21c (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c67bc43d-d341-47c6-8b81-a7ad4cdb1207 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2bb3a2d1-76c4-42e6-8553-aa95f263175b (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b069fd8-26b9-459e-abfb-de28c012ddcb (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ddbf623f-8b6f-4e8d-87d3-dc890c0ab875 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cac718b8-64bc-4aca-9b22-f2b00077bd41 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3dd83384-09b5-da46-e063-6394a90a558c (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a2f333af-d37b-4705-ab7a-d363e3186e6e (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:68c94fb4-3018-44af-b982-2b4b6d461e6f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5b73a90e-b883-419b-b30f-a379eed764d9 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0a1f7d44-c339-a4dd-e063-6294a90ac0de (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:30b94d67-0000-a045-e063-6394a90ade32 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e25a13c3-a173-4cc3-99d3-0be43abbc498 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b559c20d-70be-41e7-acfb-262ffc3ea878 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8c8bcba9-eaeb-aa44-f9ea-b580de55a439 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7e5e76cf-2fda-4f9d-bcbf-f77b1f188ee6 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dc97a895-8c2f-4891-85f3-7f45e2396140 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:623b9672-b41e-4ec9-b2cc-f5bb383c39ba (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5e91adad-9757-49e4-a3f1-1db0ef396416 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c26a87a-b2b6-4302-bb8d-2031461f28ce (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56442b06-c135-a035-e063-6394a90a171b (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f6346a11-88b9-4425-b08d-a22f19c4ceb4 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bd86b293-dab9-4d37-95eb-2bffca335d16 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0b4b9c9-bd5b-4900-8abf-b55d3283c53c (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7be6a62e-0e85-47c8-8793-b41c51c2557f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e93391c9-db88-4fa5-b1d5-f6c6de78b31c (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f705f743-40e9-42bf-88f5-6dd7e5d5ba94 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c0cc1b03-ba35-4a2c-be95-2d9b7f4c3499 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:473d6055-b811-4ffb-9398-88f50a152196 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b497dfeb-a48c-4f2a-b309-b56f3a26a19b (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7f62789b-61df-4b7b-9e01-c7a4dfb7e73c (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dfc9fee6-c032-4994-9f14-5beaf39bb5d5 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:518caa95-2cd7-a293-e063-6394a90adbd0 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:544d1ed1-da06-976d-e063-6394a90afe79 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91e24d17-ff0a-449c-9472-b9df74c98456 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:957ba196-0b9b-4cda-bd15-28357ced8d2f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0621fe8d-fdee-4d4c-a8e3-97f729472a58 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:40be43b2-649b-0928-e063-6394a90a3b48 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:22c4b114-5f70-4c64-aa7f-b4169729b847 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:01800452-c353-4235-a66a-214048752e74 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:00179766-980b-44b0-99d3-1fee2bb27e37 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e98ee4c-24df-88ce-e053-2a95a90a6713 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6ed2b9b7-e4af-4e28-a7d5-4ccb514af217 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:680890b1-bc45-4f50-9aaf-e730ab515b85 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2beb45ca-0ebb-4908-807a-7413250693e3 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f5a71b2-2821-46a0-ac65-28d9b2db73ec (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:48702ef4-21cd-754e-e063-6394a90af24e (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:23f1c8c5-032c-4ea9-beb0-ca3a614ba4b6 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c614be38-cb45-44a1-b78e-0cdfc0691618 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:561a8a20-be26-c4f8-e063-6394a90af072 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:561e7498-a606-366d-e063-6394a90a1c6a (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5f0616f6-433f-45c9-86f4-f802fda5d891 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14c4fa96-8919-4ea7-ad72-129f288d8cfc (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0f264823-1cba-4478-aef1-a8587f221dbb (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e105aeb-6e17-a025-e053-2995a90aba77 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4191b929-5bdb-4388-9e4d-fffce55bc363 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ab962a5a-fff6-2cf9-e053-2995a90ace0f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1548faf9-8625-f871-e063-6394a90a931f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5921f77f-01a2-40b9-ad77-2258865c997d (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:677c90cd-6527-40cb-a564-571796513fcb (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91b4c802-9c6b-49bb-b5a7-661e1917ef34 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b400fed8-f425-47ff-ab42-915cb6e7f152 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:205ecf52-8138-44a7-ad9a-b3aa7f4fa11a (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:84aba223-04ae-479c-b5dd-e04fab45045d (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ab1bb71f-936d-cb40-e053-2a95a90a08bb (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:575da603-b038-421f-9894-6796d9ac33cc (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55f514c6-f6ec-13ac-e063-6294a90ac957 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cf71d1b9-5ebb-429f-a07f-a87cd168250f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:adfcc867-1b6e-4698-94b6-2b4190c4ba3d (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:42120ff8-b353-4632-9ea9-54de9a698724 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:513ecb5b-062f-455f-b798-1c9a54222ff3 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e815c67d-951c-4cb3-a840-f0b493b97da1 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:75a43476-25e0-44c3-bbab-2160041032d1 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f81b0c4-9ad9-4dda-8950-70321a8769e4 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4e09f580-d612-416c-a4a4-79a4411845b2 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ae3be25b-2bde-4142-ad56-920a96ac8f39 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:50d0aef5-ecc7-49b0-964a-53f87058d22a (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4da914d0-629e-4766-b57f-6119fa8283cf (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fda754f6-d0f3-4dce-a17a-927d64f912f7 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a06f2cf6-ccef-47bf-aba8-a42bada46d8b (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:50b54bfa-0b90-44f1-8f73-4f7f552449c4 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e46bc887-69e2-4037-be59-6513277d157b (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4f94a6d7-8719-834c-e063-6294a90a3448 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8d444aec-cf33-b769-e053-2995a90a54be (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9c0a7f78-9cac-4e82-b971-f3f9758f8a0c (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e554537c-9469-4f9a-9157-d5763bb8b720 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9d49e2cb-a852-403d-b92b-e7d3fa88032c (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ab30b0a4-6696-19da-e053-2995a90a29aa (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25aef6c1-9964-44a1-a905-c37e5c28a3c0 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6dd71a5b-1923-54fb-e053-2991aa0a619e (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa260c6c-9f6a-46a3-91ce-5665739d87e7 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8c45a99-18ed-0e1f-e053-6394a90a2d52 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c4bad433-623b-402c-b454-d39f19a23627 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:455c8416-c878-4283-a42f-4df896870a4e (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:39a85db1-9e59-4ab0-9e18-36757f019faa (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45af84f5-c284-4e82-ad3c-e9b7ab2b8114 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:90524e6e-c34f-43eb-8c30-d99faf7ae08f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:96dedceb-81ad-447c-800e-800cf473d4e4 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e1864a7e-44b9-4399-9554-0c18b46fbdd6 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bdbcb3ce-e424-43eb-9f1a-77eda4dfbdaa (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5103d12c-9453-a855-e063-6294a90a6f0c (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aa13261f-46a7-4381-8084-b3ad46221e2f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:730448bf-2d78-44a4-e053-2991aa0ada9e (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:35dea1a2-ec26-4e52-8f09-ee4678e77946 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fd8a815e-88b7-4bef-9e32-6dbc735711a3 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e0adb991-ec4e-4cd1-b54e-6d8c731a1d59 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7cadc747-5606-8efe-e053-2991aa0a1d8f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6b532e6a-b040-4a10-a242-fb6d8dfc0852 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ec1b68d3-ff55-d0a2-e053-2a95a90a2e0b (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3a3efb5f-b24a-438d-9253-371ff3b5417d (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7efc1dd5-8671-4bed-9c16-ef6b9f36afc4 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0de9e3e3-912a-428b-89d2-70811a56cdc5 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ab0b0ef7-155b-cec9-e053-2a95a90a9fce (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e0e1f35e-114d-bb39-34f1-70208b94ac9e (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f515d1e7-5803-4797-b3cc-8dbea85d96e5 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:98960cc1-1d44-4d89-b415-7e250cc762cc (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7f81de84-0ad7-f050-e053-2a91aa0aa762 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61835f25-bfe4-49ac-9dbf-3d6387866e78 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52c88667-c67e-4d42-b319-afb354713b1e (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e919f195-0ce1-4d71-9883-efec05b9a050 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b5e98b93-d8f8-4eed-8a0a-63b347b670ed (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:551d5946-00df-4608-96a2-b29f0ef93ba0 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:286b429d-62b9-4ca8-a243-de3f619315bf (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:71224928-685a-355c-e053-2995a90a0a5b (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7f144b68-ae90-483c-b030-f6824662a734 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c6897cf2-1349-400d-ab22-1e88f097b693 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cbc2bd3b-03fc-47b9-91d1-8989ec90c7e6 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2533b60-cc54-4905-a4ee-ea08a160f8c6 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1afd0016-d0ee-4e25-a1a4-b66f228e2f9c (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ca30f3f-545e-46c5-b56a-73ec48e9647f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a5c49e6e-b8e0-4a75-99e6-b88e323ce653 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9bc362d4-489c-4e7f-915a-3076ff8d132a (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:03e1f274-fa9a-4461-b7c9-31ba6428c107 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:268bd7f7-bc17-4850-ab7c-1b73caa564d5 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:444ca054-e450-4c10-a31b-71ad43946cb8 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
The average terminal elimination half-life of plasma sertraline is about 26 hours.
Projected row 1392
- Medicine slug
- sertraline
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 163
- Source count
- 163
- Agreement rate
- 1
- Recorded readings
98%
- Numeric value
- 98
- Unit
- %
- Source records
- 163
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 163 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a6d0f35c-f4f4-456d-b8d9-d56297261ad6 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Distribution In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ddfd698-3d47-fc0e-e063-6394a90accec (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4cf8d5c8-842b-4e7c-9a99-3f41ef8abbdb (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fd92c8d3-17ec-477c-bc25-e5239c8606ac (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ad69cbfe-5b42-4714-a999-77d474e0849d (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de1f85ac-df1b-4b7b-8e18-48ebdc8b9279 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af2c75a3-131e-4bde-83fd-310fd2c01161 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:626a9271-a268-4194-935d-779377f902f5 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5c6c817e-a555-4f55-837d-94458787fcb6 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1766ea8b-bb88-8bb8-e063-6394a90a032d (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9bcef7ef-4e2f-4ab9-9c0f-f4956bfdd71b (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ac8a624-2292-b7b8-e063-6394a90a165b (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4f6f2412-8085-45bf-be4f-63e44490a34e (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0e5a7b02-3972-47f0-9f49-e958d792beac (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:10b9cae4-b452-4abb-866a-9f9d2568f212 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 ng/mL to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7d598f1a-6c76-458a-a155-7a6a0743a2d3 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:664d1744-7b1d-43e2-98ba-1b0e69d75840 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:10baaffd-061e-d665-e063-6294a90a1594 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1fcd3f6d-a71f-b131-e063-6394a90a4b26 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7b5c29ff-25c8-4b68-844d-b8e95be7d09b (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:056191ca-999a-4c9b-93b9-64db44b8e628 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:345271ff-6a48-4888-a8d0-5a8ad60c7a21 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:82a44e20-d0ee-4ed7-9234-24ef4496ac1d (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 ng to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ba201164-f6f7-4779-87a3-62780f332113 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:787a683a-091c-4908-a643-ecbc8fd467eb (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding – In vitro protein binding studies performed with radiolabeled 3 H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f5bf9595-d9f9-40b1-9b3b-da277fd5ab7f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9f1d5689-3bf1-431c-9ea2-9e37217ecf40 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ce05049-030f-3e8b-e063-6394a90a4885 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a58062b-e635-431a-908d-2651c6a4a21c (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c67bc43d-d341-47c6-8b81-a7ad4cdb1207 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2bb3a2d1-76c4-42e6-8553-aa95f263175b (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b069fd8-26b9-459e-abfb-de28c012ddcb (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ddbf623f-8b6f-4e8d-87d3-dc890c0ab875 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cac718b8-64bc-4aca-9b22-f2b00077bd41 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3dd83384-09b5-da46-e063-6394a90a558c (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a2f333af-d37b-4705-ab7a-d363e3186e6e (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:68c94fb4-3018-44af-b982-2b4b6d461e6f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 ng to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5b73a90e-b883-419b-b30f-a379eed764d9 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0a1f7d44-c339-a4dd-e063-6294a90ac0de (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:30b94d67-0000-a045-e063-6394a90ade32 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e25a13c3-a173-4cc3-99d3-0be43abbc498 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b559c20d-70be-41e7-acfb-262ffc3ea878 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8c8bcba9-eaeb-aa44-f9ea-b580de55a439 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Distribution In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7e5e76cf-2fda-4f9d-bcbf-f77b1f188ee6 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dc97a895-8c2f-4891-85f3-7f45e2396140 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 ng to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:623b9672-b41e-4ec9-b2cc-f5bb383c39ba (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Distribution In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5e91adad-9757-49e4-a3f1-1db0ef396416 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 ng to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c26a87a-b2b6-4302-bb8d-2031461f28ce (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56442b06-c135-a035-e063-6394a90a171b (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f6346a11-88b9-4425-b08d-a22f19c4ceb4 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bd86b293-dab9-4d37-95eb-2bffca335d16 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0b4b9c9-bd5b-4900-8abf-b55d3283c53c (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7be6a62e-0e85-47c8-8793-b41c51c2557f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e93391c9-db88-4fa5-b1d5-f6c6de78b31c (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f705f743-40e9-42bf-88f5-6dd7e5d5ba94 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c0cc1b03-ba35-4a2c-be95-2d9b7f4c3499 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:473d6055-b811-4ffb-9398-88f50a152196 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b497dfeb-a48c-4f2a-b309-b56f3a26a19b (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7f62789b-61df-4b7b-9e01-c7a4dfb7e73c (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dfc9fee6-c032-4994-9f14-5beaf39bb5d5 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Distribution In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:518caa95-2cd7-a293-e063-6394a90adbd0 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:544d1ed1-da06-976d-e063-6394a90afe79 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91e24d17-ff0a-449c-9472-b9df74c98456 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:957ba196-0b9b-4cda-bd15-28357ced8d2f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0621fe8d-fdee-4d4c-a8e3-97f729472a58 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Distribution In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:40be43b2-649b-0928-e063-6394a90a3b48 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:22c4b114-5f70-4c64-aa7f-b4169729b847 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:01800452-c353-4235-a66a-214048752e74 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:00179766-980b-44b0-99d3-1fee2bb27e37 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding – In vitro protein binding studies performed with radiolabeled 3 H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e98ee4c-24df-88ce-e053-2a95a90a6713 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6ed2b9b7-e4af-4e28-a7d5-4ccb514af217 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:680890b1-bc45-4f50-9aaf-e730ab515b85 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2beb45ca-0ebb-4908-807a-7413250693e3 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 ng to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f5a71b2-2821-46a0-ac65-28d9b2db73ec (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:48702ef4-21cd-754e-e063-6394a90af24e (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:23f1c8c5-032c-4ea9-beb0-ca3a614ba4b6 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Distribution In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 ng/mL to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c614be38-cb45-44a1-b78e-0cdfc0691618 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:561a8a20-be26-c4f8-e063-6394a90af072 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:561e7498-a606-366d-e063-6394a90a1c6a (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5f0616f6-433f-45c9-86f4-f802fda5d891 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14c4fa96-8919-4ea7-ad72-129f288d8cfc (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 ng to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0f264823-1cba-4478-aef1-a8587f221dbb (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e105aeb-6e17-a025-e053-2995a90aba77 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4191b929-5bdb-4388-9e4d-fffce55bc363 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ab962a5a-fff6-2cf9-e053-2995a90ace0f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1548faf9-8625-f871-e063-6394a90a931f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5921f77f-01a2-40b9-ad77-2258865c997d (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:677c90cd-6527-40cb-a564-571796513fcb (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91b4c802-9c6b-49bb-b5a7-661e1917ef34 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b400fed8-f425-47ff-ab42-915cb6e7f152 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:205ecf52-8138-44a7-ad9a-b3aa7f4fa11a (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 ng to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:84aba223-04ae-479c-b5dd-e04fab45045d (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ab1bb71f-936d-cb40-e053-2a95a90a08bb (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:575da603-b038-421f-9894-6796d9ac33cc (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55f514c6-f6ec-13ac-e063-6294a90ac957 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cf71d1b9-5ebb-429f-a07f-a87cd168250f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:adfcc867-1b6e-4698-94b6-2b4190c4ba3d (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:42120ff8-b353-4632-9ea9-54de9a698724 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:513ecb5b-062f-455f-b798-1c9a54222ff3 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e815c67d-951c-4cb3-a840-f0b493b97da1 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:75a43476-25e0-44c3-bbab-2160041032d1 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f81b0c4-9ad9-4dda-8950-70321a8769e4 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4e09f580-d612-416c-a4a4-79a4411845b2 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ae3be25b-2bde-4142-ad56-920a96ac8f39 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:50d0aef5-ecc7-49b0-964a-53f87058d22a (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4da914d0-629e-4766-b57f-6119fa8283cf (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fda754f6-d0f3-4dce-a17a-927d64f912f7 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a06f2cf6-ccef-47bf-aba8-a42bada46d8b (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:50b54bfa-0b90-44f1-8f73-4f7f552449c4 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e46bc887-69e2-4037-be59-6513277d157b (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4f94a6d7-8719-834c-e063-6294a90a3448 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8d444aec-cf33-b769-e053-2995a90a54be (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9c0a7f78-9cac-4e82-b971-f3f9758f8a0c (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e554537c-9469-4f9a-9157-d5763bb8b720 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9d49e2cb-a852-403d-b92b-e7d3fa88032c (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ab30b0a4-6696-19da-e053-2995a90a29aa (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25aef6c1-9964-44a1-a905-c37e5c28a3c0 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3 H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6dd71a5b-1923-54fb-e053-2991aa0a619e (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa260c6c-9f6a-46a3-91ce-5665739d87e7 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8c45a99-18ed-0e1f-e053-6394a90a2d52 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c4bad433-623b-402c-b454-d39f19a23627 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:455c8416-c878-4283-a42f-4df896870a4e (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:39a85db1-9e59-4ab0-9e18-36757f019faa (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45af84f5-c284-4e82-ad3c-e9b7ab2b8114 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:90524e6e-c34f-43eb-8c30-d99faf7ae08f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:96dedceb-81ad-447c-800e-800cf473d4e4 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Distribution In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 ng/mL to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e1864a7e-44b9-4399-9554-0c18b46fbdd6 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bdbcb3ce-e424-43eb-9f1a-77eda4dfbdaa (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5103d12c-9453-a855-e063-6294a90a6f0c (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aa13261f-46a7-4381-8084-b3ad46221e2f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 ng to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:730448bf-2d78-44a4-e053-2991aa0ada9e (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 ng to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:35dea1a2-ec26-4e52-8f09-ee4678e77946 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3 H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fd8a815e-88b7-4bef-9e32-6dbc735711a3 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e0adb991-ec4e-4cd1-b54e-6d8c731a1d59 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7cadc747-5606-8efe-e053-2991aa0a1d8f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6b532e6a-b040-4a10-a242-fb6d8dfc0852 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding– In vitro protein binding studies performed with radiolabeled 3 H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ec1b68d3-ff55-d0a2-e053-2a95a90a2e0b (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3a3efb5f-b24a-438d-9253-371ff3b5417d (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Distribution In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7efc1dd5-8671-4bed-9c16-ef6b9f36afc4 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0de9e3e3-912a-428b-89d2-70811a56cdc5 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ab0b0ef7-155b-cec9-e053-2a95a90a9fce (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e0e1f35e-114d-bb39-34f1-70208b94ac9e (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Distribution In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f515d1e7-5803-4797-b3cc-8dbea85d96e5 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:98960cc1-1d44-4d89-b415-7e250cc762cc (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7f81de84-0ad7-f050-e053-2a91aa0aa762 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61835f25-bfe4-49ac-9dbf-3d6387866e78 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52c88667-c67e-4d42-b319-afb354713b1e (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e919f195-0ce1-4d71-9883-efec05b9a050 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 ng to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b5e98b93-d8f8-4eed-8a0a-63b347b670ed (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:551d5946-00df-4608-96a2-b29f0ef93ba0 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding – In vitro protein binding studies performed with radiolabeled 3 H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:286b429d-62b9-4ca8-a243-de3f619315bf (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:71224928-685a-355c-e053-2995a90a0a5b (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7f144b68-ae90-483c-b030-f6824662a734 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c6897cf2-1349-400d-ab22-1e88f097b693 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cbc2bd3b-03fc-47b9-91d1-8989ec90c7e6 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2533b60-cc54-4905-a4ee-ea08a160f8c6 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1afd0016-d0ee-4e25-a1a4-b66f228e2f9c (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ca30f3f-545e-46c5-b56a-73ec48e9647f (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a5c49e6e-b8e0-4a75-99e6-b88e323ce653 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Distribution In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 ng/mL to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9bc362d4-489c-4e7f-915a-3076ff8d132a (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:03e1f274-fa9a-4461-b7c9-31ba6428c107 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:268bd7f7-bc17-4850-ab7c-1b73caa564d5 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:444ca054-e450-4c10-a31b-71ad43946cb8 (opens source in a new tab)
Sertraline label
Version not recorded · Effective date not recorded
Protein Binding In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.
Projected row 1393
- Medicine slug
- sevelamer
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 10
- Source count
- 10
- Agreement rate
- 1
- Recorded readings
50%
- Numeric value
- 50
- Unit
- %
- Source records
- 10
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 10 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:35337152-9b92-40c0-e063-6294a90a8dd5 (opens source in a new tab)
Sevelamer label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 g of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3533d24b-508e-f012-e063-6394a90acaf5 (opens source in a new tab)
Sevelamer label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 g of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6926ebbe-2d74-4d5f-b642-c1bfe3a4e305 (opens source in a new tab)
Sevelamer label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 g of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d8729e42-dbbd-4954-9ce0-298743a15a06 (opens source in a new tab)
Sevelamer label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 g of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a56c857e-bc39-484c-908d-f5957857efbb (opens source in a new tab)
Sevelamer label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 g of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ddecb552-5882-4e44-8fa7-37c9234dd1b9 (opens source in a new tab)
Sevelamer label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 g of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c13532a7-4c56-4084-839d-3dcfd4dc30f8 (opens source in a new tab)
Sevelamer label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 g of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2cd6512f-0edd-4a30-a4fa-aa996038633c (opens source in a new tab)
Sevelamer label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 g of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0500034d-458c-42c5-918d-9acd22f0c28b (opens source in a new tab)
Sevelamer label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 g of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8830526f-d957-423e-84ea-e4d79346948b (opens source in a new tab)
Sevelamer label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 g of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
Projected row 1394
- Medicine slug
- sevelamer-carbonate
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 40
- Source count
- 40
- Agreement rate
- 1
- Recorded readings
50%
- Numeric value
- 50
- Unit
- %
- Source records
- 40
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 40 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5baf3742-5929-42f8-8865-6b3e92647d5b (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ea201bff-cdfb-4304-bdb1-d05c1dac2677 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:da5239fe-060b-4469-95ac-173adec43b9c (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Co-administered single-dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6328460-a57b-450b-a48c-6dcd4b476360 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:649e5b7b-aa2f-4975-8c00-01d647d35c01 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:51ce2ed6-3acf-a6ea-e063-6294a90a21aa (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4c927d50-34a6-499b-b1c2-924d4eb73987 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8947f65-57be-4af7-b0e7-17666f496d01 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ccf62c6-dbad-416d-8e02-631795bd7517 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:134f32c1-b5d5-44d0-9da5-85033e99320a (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bd0a89ab-91c4-42b3-aa88-1e3295d0d344 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05b076d9-6516-4538-8e05-9709a677ed2f (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ee9da697-2d55-48e5-8e03-c64c8aaf1fb8 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Co-administered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:09b5e422-18c9-49dc-be3d-5d24648184af (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Co-administered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:462a11b9-78a3-4d8b-ae5d-3d6528e4d743 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3abc32fe-1bfc-4759-8f7c-36095e221b06 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ab0cd45f-0c4b-4ce7-bf8e-5f98d43feaab (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:42fefb90-6941-4539-8f32-df1896223450 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:41890246-efa5-524a-e063-6294a90a5ad9 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d2f0c283-3e9d-41db-bd4d-83bd21f2a019 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ccfde4dd-b258-4baf-995b-a24bed8c84d7 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45a955e9-94ac-48db-838c-74934eae245b (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:71f61492-8971-424a-8415-dfd2e15d05d9 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:07b709fd-a2a1-4ff1-ad19-827d38e84562 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Co-administered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0085356d-5fec-3cce-2bd3-108be70e515d (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:48dbd7a7-32c7-45c1-ac8b-c478cf3282a6 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:65184825-adce-480e-a4c3-b21e37656cf4 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7f701cb4-3089-375f-e053-2991aa0a51b9 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Co-administered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c17bff97-8347-43f8-822e-1cb9736562b6 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0cade89a-38ca-4072-97a0-be09c6e058f4 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:94d8cfb1-ff2a-4956-8954-17635ac505d9 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Co-administered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f63450bd-d075-4810-a277-e8bc41e4a5af (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Co-administered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c3cf4807-ae5f-528e-e053-2a95a90ac640 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Co-administered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61d073ec-51a4-48c7-8762-25fdd00fe6ac (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9b4d0720-f4e7-4b4f-affc-57ce8bb0b722 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:568b8558-6117-4c2f-aabf-86e567b38863 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Co-administered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3779296e-35bc-5b03-e063-6294a90a0214 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f6455fa3-ad53-f6fd-e053-2a95a90a67db (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b72baeeb-b6f5-4fa1-bee8-9eb4bb74dc82 (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:515ae758-ccba-5758-e063-6394a90a315b (opens source in a new tab)
Sevelamer Carbonate label
Version not recorded · Effective date not recorded
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.
Projected row 1395
- Medicine slug
- sevoflurane
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 13
- Source count
- 13
- Agreement rate
- 1
- Recorded readings
15-23 hours
- Numeric value
- 15
- Unit
- hours
- Source records
- 13
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 13 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fedfd1db-7e32-44b2-89e9-7bb00ee6810d (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
The half-life is in the range of 15-23 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:22700993-851a-48aa-941e-1d2b6b04081f (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
The half-life is in the range of 15-23 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bdde7502-6218-401c-9a4f-dd3bc3a80f72 (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
The half-life is in the range of 15 to 23 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0ca6da3a-6a18-400d-8c49-08a5534b025f (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
The half-life is in the range of 15-23 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:06b9f724-6425-4976-93eb-b9ca343ef5cf (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
The half-life is in the range of 15-23 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c808afe1-ebf1-44cf-9187-09656331bff5 (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
The half-life is in the range of 15-23 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4c6e76bc-c964-4955-e0a3-511d3386a9cc (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
The half-life is in the range of 15-23 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3dbab949-6ab7-4040-9c81-314e5bb61d41 (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
The half-life is in the range of 15-23 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c9aa6489-5a36-44ed-9512-b996833d82f7 (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
The half-life is in the range of 15-23 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8604f245-fa99-4092-9042-058aa42e0b74 (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
The half-life is in the range of 15 to 23 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b23e14d7-9e5b-13f4-e053-2a95a90a0cde (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
The half-life is in the range of 15-23 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5bfc1cef-824d-4ebf-bb4d-fbc46c0abb79 (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
The half-life is in the range of 15-23 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ea8bf997-2c71-4014-b18d-4f7ab45dfa19 (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
The half-life is in the range of 15-23 hours.
Projected row 1396
- Medicine slug
- sevoflurane
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 13
- Source count
- 13
- Agreement rate
- 1
- Recorded readings
2 hours
- Numeric value
- 2
- Unit
- hours
- Source records
- 13
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 13 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fedfd1db-7e32-44b2-89e9-7bb00ee6810d (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
As shown in Figure 6, peak concentrations occur within 2 hours of the end of anesthesia and are less than 25 μM (475 ng/mL) for the majority of the population after 10 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:22700993-851a-48aa-941e-1d2b6b04081f (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
As shown in Figure 6, peak concentrations occur within 2 hours of the end of anesthesia and are less than 25 µM (475 ng/mL) for the majority of the population after 10 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bdde7502-6218-401c-9a4f-dd3bc3a80f72 (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
As shown in Figure 6, peak concentrations occur within 2 hours of the end of anesthesia and are less than 25 µM (475 ng/mL) for the majority of the population after 10 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0ca6da3a-6a18-400d-8c49-08a5534b025f (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
As shown in Figure 6, peak concentrations occur within 2 hours of the end of anesthesia and are less than 25 µM (475 ng/mL) for the majority of the population after 10 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:06b9f724-6425-4976-93eb-b9ca343ef5cf (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
As shown in Figure 6, peak concentrations occur within 2 hours of the end of anesthesia and are less than 25 μM (475 ng/mL) for the majority of the population after 10 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c808afe1-ebf1-44cf-9187-09656331bff5 (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
As shown in Figure 6, peak concentrations occur within 2 hours of the end of anesthesia and are less than 25 M (475 ng/mL) for the majority of the population after 10 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4c6e76bc-c964-4955-e0a3-511d3386a9cc (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
As shown in Figure 6, peak concentrations occur within 2 hours of the end of anesthesia and are less than 25 µM (475 ng/mL) for the majority of the population after 10 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3dbab949-6ab7-4040-9c81-314e5bb61d41 (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
As shown in Figure 6, peak concentrations occur within 2 hours of the end of anesthesia and are less than 25 μM (475 ng/mL) for the majority of the population after 10 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c9aa6489-5a36-44ed-9512-b996833d82f7 (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
As shown in Figure 6, peak concentrations occur within 2 hours of the end of anesthesia and are less than 25 µM (475 ng/mL) for the majority of the population after 10 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8604f245-fa99-4092-9042-058aa42e0b74 (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
As shown in Figure 6 , peak concentrations occur within 2 hours of the end of anesthesia and are less than 25 µM (475 ng/mL) for the majority of the population after 10 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b23e14d7-9e5b-13f4-e053-2a95a90a0cde (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
As shown in Figure 6, peak concentrations occur within 2 hours of the end of anesthesia and are less than 25 µM (475 ng/mL) for the majority of the population after 10 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5bfc1cef-824d-4ebf-bb4d-fbc46c0abb79 (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
As shown in Figure 6, peak concentrations occur within 2 hours of the end of anesthesia and are less than 25μM (475 ng/mL) for the majority of the population after 10 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ea8bf997-2c71-4014-b18d-4f7ab45dfa19 (opens source in a new tab)
Sevoflurane label
Version not recorded · Effective date not recorded
As shown in Figure 6, peak concentrations occur within 2 hours of the end of anesthesia and are less than 25 µM (475 ng/mL) for the majority of the population after 10 hours.
Projected row 1397
- Medicine slug
- sildenafil
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 166
- Source count
- 166
- Agreement rate
- 1
- Recorded readings
41%
- Numeric value
- 41
- Unit
- %
- Source records
- 166
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 166 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fbe75c2c-0aff-9ade-e053-6394a90a1ea4 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa14cb6b-0fa8-0ba0-e053-6294a90afae3 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
However, due to Viatris Specialty LLC's marketing exclusivity rights, this drug product is not labeled with that information. 12.3 Pharmacokinetics Absorption and Distribution Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25% to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53078688-ad66-4bb2-808c-b76acedd00e3 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25–63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:85767ed7-932b-4e2b-8bba-b59bb45ce116 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55a53f64-c04a-4697-9db3-d0827fdfcc2b (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:78101030-ef1d-44b9-e053-2991aa0a158d (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ceb575b-2687-0456-e063-6394a90aa88a (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:97ccea8a-6d5a-129f-e053-2995a90aa837 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:28a3376b-e50e-4789-9916-803ba29a1522 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3314d14e-99eb-39e5-e063-6394a90aed94 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8780c159-8b61-402b-afbe-64f5c85d3886 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:283790ed-2acb-4714-a0af-b348bb642785 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25% to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ce683bbc-a1d2-4f23-b3d1-d9333d91dc55 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil tablets is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25–63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a10b7ec1-bb59-4906-b32d-fbd2a17ed7a8 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1bc081f2-399d-43fa-9e0f-9f8df0118e99 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:187de471-3e79-44ed-b560-0f8b2d549f74 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
However, due to Viatris Specialty LLC's marketing exclusivity rights, this drug product is not labeled with that information. 12.3 Pharmacokinetics Absorption and Distribution Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25% to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a17a970e-25a2-4807-9644-74e6d2bd2383 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:15372a7c-2935-48dc-a55a-8966719b50be (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Effects of Sildenafil tablets on Sperm: There was no effect on sperm motility or morphology after single 100 mg oral doses of sildenafil tablets in healthy volunteers. figure1 figure2 figure3 figure4 12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61a0ebd9-8dc9-4bcc-b07b-f3d6398ea96e (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7d68a3d3-590b-0bd9-e053-2a91aa0ae8cd (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fcc9e04d-3507-4429-9ddd-c1fdee8acdbf (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
However, due to Viatris Specialty LLC's marketing exclusivity rights, this drug product is not labeled with that information . 12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:06571775-b651-4e23-a35b-88392aae7e13 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7086e222-0f2b-4c02-84c0-4f8635c90993 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Effects of Sildenafil tablets on Sperm: There was no effect on sperm motility or morphology after single 100 mg oral doses of sildenafil tablets in healthy volunteers. figure1 figure2 figure3 figure4 12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:43a036a4-8a34-4411-ac8e-bf5063d67d48 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:46dff4c0-9a6c-20f9-e054-00144ff8d46c (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:31c0f8ab-ed2e-4ead-a8c0-4055f6c43783 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9de0817-cac1-4ee5-e053-2a95a90a5fa7 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Effects of Sildenafil citrate on Sperm: There was no effect on sperm motility or morphology after single 100 mg oral doses of sildenafil citrate in healthy volunteers. figure-4 12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a05ab4e7-6f70-41c3-a3b7-9a2fd7a1d2d6 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Effects of Sildenafil citrate on Sperm: There was no effect on sperm motility or morphology after single 100 mg oral doses of sildenafil citrate in healthy volunteers. 12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5ac95dd0-57e4-495c-bf8d-b2e5bbe33e20 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:78c4551c-b922-43c9-9a5a-66377ea07bc2 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Effects of Sildenafil citrate on Sperm: There was no effect on sperm motility or morphology after single 100 mg oral doses of sildenafil citrate in healthy volunteers. figure-4 12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:486dcfc4-f07a-4a78-86f0-f1c5ae448dc1 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e1af7b6a-378e-4337-858f-85a926eec102 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:00ee09dd-2de0-4dc4-85f6-b51ed6eabd5b (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:49a95b25-08b3-4cfe-a60b-c5132c280be2 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:22d70b8d-41bc-416d-89e9-e4c39db0af83 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:18b327c1-19c9-4e33-ae02-de7cc900149c (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a84a418a-155c-7be7-e053-2995a90a8158 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Effects of Sildenafil Tablets on Sperm: There was no effect on sperm motility or morphology after single 100 mg oral doses of sildenafil tablets in healthy volunteers. 12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8c4f22c8-3607-4d64-8821-dd3202f8fa0a (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f7fbfc3b-807e-4375-a6eb-8db0eaf40c9c (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:428bbcff-0faf-499c-81b2-6ac76c0687c0 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics SILDENAFIL TABLETS is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25–63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e671d887-2317-4c1c-9b68-e24cda3d3aef (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25–63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:824dcd79-bc82-4b3a-8028-3c1bca1a7a0a (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e22902bd-e5a8-4df6-ae77-8a0a1484cc50 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4e3034af-bee5-4df4-8beb-fbd2b510ad73 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9213fec1-e0c0-4ef7-9718-d97922a3f4d8 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dfe4f616-b5de-458c-a97b-ab860e32320c (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25% to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b1ab00d-de9c-4614-e063-6394a90afcde (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dc38f412-dca7-4b54-b14c-314e7a251ee6 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
However, due to Viatris Specialty LLC's marketing exclusivity rights, this drug product is not labeled with that information. 12.3 Pharmacokinetics Absorption and Distribution Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25% to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3bb9363e-b28d-4019-8aae-539233dca214 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution REVATIO is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8127ff38-2761-49ec-8ce7-7f971f521cfb (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b48630b1-5208-4d00-b56f-21701f223758 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Effects of Sildenafil citrate on Sperm: There was no effect on sperm motility or morphology after single 100 mg oral doses of sildenafil citrate in healthy volunteers. figure-4 12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d35f8d6b-e642-78bb-e053-2995a90abb2e (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c079fc41-7b9a-499d-88ea-86ccb65c828d (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ae732301-384f-43ae-80d1-5e3784fe1dca (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0aced3eb-cb0b-4135-905c-b274505aa740 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7c01fd56-5dd6-4728-9f2a-e0f5db810269 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:083da718-e934-4941-b083-a19b4ebe3935 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8526e8f2-4bb4-430b-9e38-68ee68caa5a4 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:407ee7fc-0022-4fac-9fa6-4285d774fdb3 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:38a5592a-c14a-40af-a19a-588cb11090ed (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
An evaluation of visual function at doses up to 200 mg revealed no effects of sildenafil citrate on visual acuity, intraocular pressure, or pupillometry. 12.3 Pharmacokinetics Absorption and Distribution Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25% to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0bb3eb8d-05cd-b4cd-e063-6294a90a94bb (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d2892f4b-f5ba-42f5-b373-310241f4efa7 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:997197bf-7706-4e12-97df-b0a9ea6d3a10 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20ead8ca-7cec-2d80-e063-6394a90af548 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1ee9139-13ac-7d5b-e053-2995a90a8e50 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
An evaluation of visual function at doses up to 200 mg revealed no effects of sildenafil tablets on visual acuity, intraocular pressure, or pupillometry. 12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:155c7549-b7d6-0c06-e063-6294a90ac65c (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:30cb7d6a-ce40-c794-e063-6294a90a6861 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:98a9897b-0cbc-4ea6-9ac2-4dd719a2ede0 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7dd302cd-b84d-4d7d-bd1e-2916febbaea5 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:41b67fd2-3d9a-49d6-88b8-285044b98dc1 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f3089ee6-190d-4749-e053-2a95a90a15d8 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5f9ff0bb-5634-437a-96eb-249b910c7e81 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Effects of Sildenafil citrate on Sperm: There was no effect on sperm motility or morphology after single 100 mg oral doses of sildenafil citrate in healthy volunteers. figure-4 figure-1 12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:363c1e77-e482-47b2-aa1e-851abd770aeb (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:333ca682-931f-4edb-95d6-2edbd87631cf (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8864c64-22ad-402b-a1e8-cfb53fa02e80 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil tablets is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25–63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9ebc1a11-3f4b-4eb3-89f5-f430a330887d (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil tablets is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25–63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61c3866e-401d-48b3-a0d2-1e24a33ab512 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:94eb1f59-2a7d-4230-9ae6-69c34d083326 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f66ce83b-bad6-4180-a8c4-8475a8ec50b7 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5cbac450-f336-45bd-8d10-9ecfd21866eb (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a9f0e832-e85c-975f-e053-2995a90afa22 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5846bff2-6a93-46a7-a547-04459c590814 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f98d51a5-e3c8-2b6c-e053-6294a90ac146 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25% to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ccc6fa6-f8ae-4191-806f-a887244e516a (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e08de794-9b7e-aae6-9c89-a0c0d090cc76 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
However, due to Viatris Specialty LLC’s marketing exclusivity rights, this drug product is not labeled with that information. 1 12.3 Pharmacokinetics Absorption and Distribution Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25% to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1add0cab-8873-4cd1-ab53-e05c4ac458b1 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:21c83ff3-c359-3269-e063-6394a90a57ee (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
However, due to Viatris Specialty LLC's marketing exclusivity rights, this drug product is not labeled with that information. 12.3 Pharmacokinetics Absorption and Distribution Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25% to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e5ad3ce5-29ee-4b55-a67a-0f28c23a3afa (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25–63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4df47282-7950-9430-e063-6394a90af579 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25- 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d905dc8d-917f-4ea3-a4ee-a1ecf6967d4e (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics VIAGRA is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:18bd4315-2446-415b-a6a3-991ba0035768 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52614168-3a9e-335d-e063-6394a90ac27f (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Effects of Sildenafil citrate on Sperm: There was no effect on sperm motility or morphology after single 100 mg oral doses of sildenafil citrate in healthy volunteers. figure-4 12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e4f41e9e-d508-4f91-8677-8a19b07139de (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f1122baa-8dee-43fc-bd3d-501a55b696b3 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0500a861-359f-4e12-beb5-0cac8cd6ae1c (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0b0be196-0c62-461c-94f4-9a35339b4501 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics VIAGRA is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25–63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:34845de2-9b11-49c0-b684-cc8efb31386a (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9de84092-ebe6-436c-a925-88a6e3861eba (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25% to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:59b623bc-fbdd-4f32-8327-0d600763f429 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d614710-708e-f11c-e063-6394a90a05a5 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d887377e-90c5-44dc-8455-b23a6755b36f (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b60b4fdc-9b78-45e6-8438-8a30f83ed976 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4c57d855-3b49-fe6e-e063-6294a90a5cd5 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a65b5fb3-ca3c-4226-9caa-42fb9a2f7373 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:99bc66a4-05d1-4372-a25a-1153d7af580e (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:96ae6733-cef9-46cf-bf4e-5368201943bd (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25% to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c5ac2265-393a-4fbe-b974-1dd0b9243ec8 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:36da8e3a-d17c-e42f-e063-6394a90a1ece (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Effects of Sildenafil citrate on Sperm: There was no effect on sperm motility or morphology after single 100 mg oral doses of sildenafil citrate in healthy volunteers. figure-4 12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0e6428c0-e0e9-4fc0-8615-6a9678d2286c (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9415142-a5ac-45c0-a7c2-fb1fb6751f3d (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cdab7ef5-39cb-45cc-b2bf-5f634f2f5499 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Figure 2 Figure 3 Figure 4 Figure 5 12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eaeab74e-38cc-4621-9ce8-8a5d74a29a9e (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0b734f4-9347-484d-b307-d493ae50ee54 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
However, due to Viatris Specialty LLC's marketing exclusivity rights, this drug product is not labeled with that information. 12.3 Pharmacokinetics Absorption and Distribution Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25% to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dc4430cc-8238-4d6d-99ff-bbb9d0b51bd1 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df1cc749-caec-4bf0-aa4d-db9dcc5257c3 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Effects of Sildenafil Tablets on Sperm: There was no effect on sperm motility or morphology after single 100 mg oral doses of sildenafil tablets in healthy volunteers. figure1 figure2 figure3 figure4 12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:edb0919d-cbf1-4968-b0eb-342aa811c2ce (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Effects of Sildenafil citrate on Sperm: There was no effect on sperm motility or morphology after single 100 mg oral doses of sildenafil citrate in healthy volunteers. 12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:48c56418-0e45-083f-e063-6294a90a57b3 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7d13bf00-8daf-3087-a0b8-abb1fc572467 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
However, due to Viatris Specialty LLC's marketing exclusivity rights, this drug product is not labeled with that information. 12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:90477a51-63ba-43f4-a74b-4659a946093c (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:512d1dbe-2d07-b3e0-e063-6394a90ae008 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
However, due to Viatris Specialty LLC's marketing exclusivity rights, this drug product is not labeled with that information. 12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dc1c1ddb-f16b-4d7a-aabe-cf8bdf8b7998 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ca5555d-fd45-467b-8b1d-4fbe1404f1f3 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
However, due to Viatris Specialty LLC's marketing exclusivity rights, this drug product is not labeled with that information . 12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:471b8574-cb2a-1670-e063-6394a90a2a84 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil tablets is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25–63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b9b1d6ee-da42-4ef2-ab93-cd36d7f34150 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf1a22a2-6a69-46c9-933d-e474e88637e9 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:845e6f49-2d5d-48b1-9ce5-26351536cbff (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25% to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2538995d-2df6-4c87-978a-5513c670b60f (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af5277be-124b-4541-b6b2-bb55246cb8ed (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9ab796c-1912-4137-abec-e8336a850a58 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:28f2af84-f4d4-acfe-e063-6294a90ae128 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:878b4c44-cddc-42cb-b9b5-911451ad1530 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:41b2c017-53a0-c687-e063-6394a90a15b2 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2916e6c4-bc68-c4d6-e063-6394a90aba79 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17621e92-79a0-46aa-86c7-ea179e81928d (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
However, due to Viatris Specialty LLC's marketing exclusivity rights, this drug product is not labeled with that information . 12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2f04ce4-f19c-403d-8a83-74f123e5d30a (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dc998a9c-0770-111b-e053-2a95a90a88a4 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics SILDENAFIL TABLETS is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25–63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cc3656ac-3a38-a650-e053-2a95a90a912a (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f5113b5e-9087-4397-86bc-5ea10413c429 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
However, due to Viatris Specialty LLC's marketing exclusivity rights, this drug product is not labeled with that information. 12.3 Pharmacokinetics Absorption and Distribution Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25% to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ace2bb56-4992-49fe-9311-535b12eea9b4 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Effects of Sildenafil citrate on Sperm: There was no effect on sperm motility or morphology after single 100 mg oral doses of sildenafil citrate in healthy volunteers. figure-4 12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9143e0ab-0fa1-4718-919c-ddfd1e9b8386 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25- 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3522bdcc-8113-4562-8ca1-f3eb884beaea (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be6d1015-306d-44fb-8d4d-01724b8d9590 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5a14da46-a3ac-495f-bd9c-6e46d1ba6d7c (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6d8dbaa6-d61a-46ae-a641-f664104f4714 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25–63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0fa4162-e1b7-4293-ab7d-c5b375779060 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:88825206-1b91-4d95-876c-71100912d378 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil tablets is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25–63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:72900ed9-dbab-3f7b-e053-2a91aa0a0d24 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6d79946b-72a9-4d1b-a84b-9d1a679a82e2 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:30ce6e7f-716e-4a68-a4fb-2bb2d34ed052 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ef4d02f-76ee-4f67-9f4f-1cd554decb31 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:96ab1605-e171-4e86-b357-2d9378f7a05a (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f158fe10-d5dc-4432-b2c9-fc665401291b (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution REVATIO is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a1c3a2a2-8cf5-41c3-9c86-54290570d916 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25% to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1883785c-a1a4-48fe-b722-afacf2875ca8 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Figure 2 Figure 3 Figure 4 Figure 5 12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:174ef537-e3e6-42bd-a478-47b930ddc761 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fe848310-57d8-4492-829c-3e2535754a55 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:72c1516f-8a0c-495c-b11f-93bdc574ad21 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3145ceda-8c1e-4601-8a9d-5fc4978226d6 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7925711e-2e89-fd93-e053-2991aa0a507f (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil tablets are rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f925abbe-4977-00b0-e053-6294a90a6e53 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
An evaluation of visual function at doses up to 200 mg revealed no effects of sildenafil citrate on visual acuity, intraocular pressure, or pupillometry. 12.3 Pharmacokinetics Absorption and Distribution Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:591a4ae7-e06c-42b6-85af-f03fd2fb8959 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c2b25818-99a3-474b-a04c-929df1110834 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25- 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:71140bd5-0a51-4c01-ad0d-193d08ea67dd (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9ddfd2a-1961-90f9-e053-2a95a90a7f9b (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil tablets is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25–63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bb92d686-a81e-4b91-8048-693af0534cb3 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Distribution Sildenafil is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25 to 63%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a636d3c7-af25-4148-8b4e-6f44deba700b (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
However, due to Viatris Specialty LLC's marketing exclusivity rights, this drug product is not labeled with that information. 12.3 Pharmacokinetics Absorption and Distribution Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25% to 63%).
Projected row 1398
- Medicine slug
- sildenafil
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 166
- Source count
- 9
- Agreement rate
- 1
- Recorded readings
2.9 to 4.4 hours
- Numeric value
- 2.9
- Unit
- hours
- Source records
- 9
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 9 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:49a95b25-08b3-4cfe-a60b-c5132c280be2 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Sildenafil plasma concentration half-life values were estimated to range from 2.9 to 4.4 hours for a range of 10 to 70 kg of body weight.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3bb9363e-b28d-4019-8aae-539233dca214 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Sildenafil plasma concentration half-life values were estimated to range from 2.9 to 4.4 hours for a range of 10 to 70 kg of body weight.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:34845de2-9b11-49c0-b684-cc8efb31386a (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Sildenafil plasma concentration half-life values were estimated to range from 2.9 to 4.4 hours for a range of 10 to 70 kg of body weight.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b60b4fdc-9b78-45e6-8438-8a30f83ed976 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Sildenafil plasma concentration half-life values were estimated to range from 2.9 to 4.4 hours for a range of 10 to 70 kg of body weight.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2f04ce4-f19c-403d-8a83-74f123e5d30a (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Sildenafil plasma concentration half-life values were estimated to range from 2.9 to 4.4 hours for a range of 10 kg to 70 kg of body weight.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ef4d02f-76ee-4f67-9f4f-1cd554decb31 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Sildenafil plasma concentration half-life values were estimated to range from 2.9 to 4.4 hours for a range of 10 kg to 70 kg of body weight.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f158fe10-d5dc-4432-b2c9-fc665401291b (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Sildenafil plasma concentration half-life values were estimated to range from 2.9 to 4.4 hours for a range of 10 to 70 kg of body weight.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f925abbe-4977-00b0-e053-6294a90a6e53 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Sildenafil plasma concentration half-life values were estimated to range from 2.9 to 4.4 hours for a range of 10 to 70 kg of body weight.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bb92d686-a81e-4b91-8048-693af0534cb3 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Sildenafil plasma concentration half-life values were estimated to range from 2.9 to 4.4 hours for a range of 10 to 70 kg of body weight.
Projected row 1399
- Medicine slug
- sildenafil
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 166
- Source count
- 9
- Agreement rate
- 1
- Recorded readings
1 hour
- Numeric value
- 1
- Unit
- hours
- Source records
- 9
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 9 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:49a95b25-08b3-4cfe-a60b-c5132c280be2 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
T max was estimated at approximately 1 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3bb9363e-b28d-4019-8aae-539233dca214 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
T max was estimated at approximately 1 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:34845de2-9b11-49c0-b684-cc8efb31386a (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
T max was estimated at approximately 1 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b60b4fdc-9b78-45e6-8438-8a30f83ed976 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
T max was estimated at approximately 1 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2f04ce4-f19c-403d-8a83-74f123e5d30a (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
T max was estimated at approximately 1 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ef4d02f-76ee-4f67-9f4f-1cd554decb31 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
T max was estimated at approximately 1 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f158fe10-d5dc-4432-b2c9-fc665401291b (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
T max was estimated at approximately 1 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f925abbe-4977-00b0-e053-6294a90a6e53 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
Tmax was estimated at approximately 1 hour.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bb92d686-a81e-4b91-8048-693af0534cb3 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
T max was estimated at approximately 1 hour.
Projected row 1400
- Medicine slug
- sildenafil
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 166
- Source count
- 166
- Agreement rate
- 1
- Recorded readings
105 L
- Numeric value
- 105
- Unit
- L
- Source records
- 166
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 166 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fbe75c2c-0aff-9ade-e053-6394a90a1ea4 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa14cb6b-0fa8-0ba0-e053-6294a90afae3 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady-state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53078688-ad66-4bb2-808c-b76acedd00e3 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:85767ed7-932b-4e2b-8bba-b59bb45ce116 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55a53f64-c04a-4697-9db3-d0827fdfcc2b (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:78101030-ef1d-44b9-e053-2991aa0a158d (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ceb575b-2687-0456-e063-6394a90aa88a (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:97ccea8a-6d5a-129f-e053-2995a90aa837 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:28a3376b-e50e-4789-9916-803ba29a1522 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3314d14e-99eb-39e5-e063-6394a90aed94 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8780c159-8b61-402b-afbe-64f5c85d3886 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:283790ed-2acb-4714-a0af-b348bb642785 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ce683bbc-a1d2-4f23-b3d1-d9333d91dc55 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a10b7ec1-bb59-4906-b32d-fbd2a17ed7a8 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1bc081f2-399d-43fa-9e0f-9f8df0118e99 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:187de471-3e79-44ed-b560-0f8b2d549f74 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady-state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a17a970e-25a2-4807-9644-74e6d2bd2383 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:15372a7c-2935-48dc-a55a-8966719b50be (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61a0ebd9-8dc9-4bcc-b07b-f3d6398ea96e (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (V ss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7d68a3d3-590b-0bd9-e053-2a91aa0ae8cd (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fcc9e04d-3507-4429-9ddd-c1fdee8acdbf (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:06571775-b651-4e23-a35b-88392aae7e13 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7086e222-0f2b-4c02-84c0-4f8635c90993 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:43a036a4-8a34-4411-ac8e-bf5063d67d48 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (V ss ) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:46dff4c0-9a6c-20f9-e054-00144ff8d46c (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:31c0f8ab-ed2e-4ead-a8c0-4055f6c43783 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9de0817-cac1-4ee5-e053-2a95a90a5fa7 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a05ab4e7-6f70-41c3-a3b7-9a2fd7a1d2d6 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5ac95dd0-57e4-495c-bf8d-b2e5bbe33e20 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:78c4551c-b922-43c9-9a5a-66377ea07bc2 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:486dcfc4-f07a-4a78-86f0-f1c5ae448dc1 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e1af7b6a-378e-4337-858f-85a926eec102 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:00ee09dd-2de0-4dc4-85f6-b51ed6eabd5b (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:49a95b25-08b3-4cfe-a60b-c5132c280be2 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:22d70b8d-41bc-416d-89e9-e4c39db0af83 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:18b327c1-19c9-4e33-ae02-de7cc900149c (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a84a418a-155c-7be7-e053-2995a90a8158 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8c4f22c8-3607-4d64-8821-dd3202f8fa0a (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f7fbfc3b-807e-4375-a6eb-8db0eaf40c9c (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (V ss ) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:428bbcff-0faf-499c-81b2-6ac76c0687c0 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e671d887-2317-4c1c-9b68-e24cda3d3aef (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:824dcd79-bc82-4b3a-8028-3c1bca1a7a0a (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e22902bd-e5a8-4df6-ae77-8a0a1484cc50 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4e3034af-bee5-4df4-8beb-fbd2b510ad73 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9213fec1-e0c0-4ef7-9718-d97922a3f4d8 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dfe4f616-b5de-458c-a97b-ab860e32320c (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b1ab00d-de9c-4614-e063-6394a90afcde (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dc38f412-dca7-4b54-b14c-314e7a251ee6 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady-state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3bb9363e-b28d-4019-8aae-539233dca214 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8127ff38-2761-49ec-8ce7-7f971f521cfb (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b48630b1-5208-4d00-b56f-21701f223758 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d35f8d6b-e642-78bb-e053-2995a90abb2e (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c079fc41-7b9a-499d-88ea-86ccb65c828d (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ae732301-384f-43ae-80d1-5e3784fe1dca (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0aced3eb-cb0b-4135-905c-b274505aa740 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7c01fd56-5dd6-4728-9f2a-e0f5db810269 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:083da718-e934-4941-b083-a19b4ebe3935 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (V ss ) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8526e8f2-4bb4-430b-9e38-68ee68caa5a4 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:407ee7fc-0022-4fac-9fa6-4285d774fdb3 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:38a5592a-c14a-40af-a19a-588cb11090ed (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady-state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0bb3eb8d-05cd-b4cd-e063-6294a90a94bb (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d2892f4b-f5ba-42f5-b373-310241f4efa7 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:997197bf-7706-4e12-97df-b0a9ea6d3a10 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20ead8ca-7cec-2d80-e063-6394a90af548 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1ee9139-13ac-7d5b-e053-2995a90a8e50 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:155c7549-b7d6-0c06-e063-6294a90ac65c (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:30cb7d6a-ce40-c794-e063-6294a90a6861 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:98a9897b-0cbc-4ea6-9ac2-4dd719a2ede0 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7dd302cd-b84d-4d7d-bd1e-2916febbaea5 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:41b67fd2-3d9a-49d6-88b8-285044b98dc1 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f3089ee6-190d-4749-e053-2a95a90a15d8 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5f9ff0bb-5634-437a-96eb-249b910c7e81 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:363c1e77-e482-47b2-aa1e-851abd770aeb (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:333ca682-931f-4edb-95d6-2edbd87631cf (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8864c64-22ad-402b-a1e8-cfb53fa02e80 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9ebc1a11-3f4b-4eb3-89f5-f430a330887d (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61c3866e-401d-48b3-a0d2-1e24a33ab512 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:94eb1f59-2a7d-4230-9ae6-69c34d083326 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (V ss ) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f66ce83b-bad6-4180-a8c4-8475a8ec50b7 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5cbac450-f336-45bd-8d10-9ecfd21866eb (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (V ss ) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a9f0e832-e85c-975f-e053-2995a90afa22 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5846bff2-6a93-46a7-a547-04459c590814 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f98d51a5-e3c8-2b6c-e053-6294a90ac146 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ccc6fa6-f8ae-4191-806f-a887244e516a (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e08de794-9b7e-aae6-9c89-a0c0d090cc76 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady-state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1add0cab-8873-4cd1-ab53-e05c4ac458b1 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:21c83ff3-c359-3269-e063-6394a90a57ee (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady-state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e5ad3ce5-29ee-4b55-a67a-0f28c23a3afa (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4df47282-7950-9430-e063-6394a90af579 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (V ss ) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d905dc8d-917f-4ea3-a4ee-a1ecf6967d4e (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:18bd4315-2446-415b-a6a3-991ba0035768 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52614168-3a9e-335d-e063-6394a90ac27f (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e4f41e9e-d508-4f91-8677-8a19b07139de (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f1122baa-8dee-43fc-bd3d-501a55b696b3 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0500a861-359f-4e12-beb5-0cac8cd6ae1c (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0b0be196-0c62-461c-94f4-9a35339b4501 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:34845de2-9b11-49c0-b684-cc8efb31386a (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9de84092-ebe6-436c-a925-88a6e3861eba (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady-state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:59b623bc-fbdd-4f32-8327-0d600763f429 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d614710-708e-f11c-e063-6394a90a05a5 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d887377e-90c5-44dc-8455-b23a6755b36f (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b60b4fdc-9b78-45e6-8438-8a30f83ed976 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4c57d855-3b49-fe6e-e063-6294a90a5cd5 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a65b5fb3-ca3c-4226-9caa-42fb9a2f7373 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:99bc66a4-05d1-4372-a25a-1153d7af580e (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:96ae6733-cef9-46cf-bf4e-5368201943bd (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c5ac2265-393a-4fbe-b974-1dd0b9243ec8 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:36da8e3a-d17c-e42f-e063-6394a90a1ece (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0e6428c0-e0e9-4fc0-8615-6a9678d2286c (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (V ss ) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9415142-a5ac-45c0-a7c2-fb1fb6751f3d (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cdab7ef5-39cb-45cc-b2bf-5f634f2f5499 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eaeab74e-38cc-4621-9ce8-8a5d74a29a9e (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0b734f4-9347-484d-b307-d493ae50ee54 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady-state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dc4430cc-8238-4d6d-99ff-bbb9d0b51bd1 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df1cc749-caec-4bf0-aa4d-db9dcc5257c3 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:edb0919d-cbf1-4968-b0eb-342aa811c2ce (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:48c56418-0e45-083f-e063-6294a90a57b3 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7d13bf00-8daf-3087-a0b8-abb1fc572467 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:90477a51-63ba-43f4-a74b-4659a946093c (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:512d1dbe-2d07-b3e0-e063-6394a90ae008 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dc1c1ddb-f16b-4d7a-aabe-cf8bdf8b7998 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ca5555d-fd45-467b-8b1d-4fbe1404f1f3 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:471b8574-cb2a-1670-e063-6394a90a2a84 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b9b1d6ee-da42-4ef2-ab93-cd36d7f34150 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf1a22a2-6a69-46c9-933d-e474e88637e9 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:845e6f49-2d5d-48b1-9ce5-26351536cbff (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady-state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2538995d-2df6-4c87-978a-5513c670b60f (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af5277be-124b-4541-b6b2-bb55246cb8ed (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9ab796c-1912-4137-abec-e8336a850a58 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (V ss ) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:28f2af84-f4d4-acfe-e063-6294a90ae128 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:878b4c44-cddc-42cb-b9b5-911451ad1530 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:41b2c017-53a0-c687-e063-6394a90a15b2 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2916e6c4-bc68-c4d6-e063-6394a90aba79 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17621e92-79a0-46aa-86c7-ea179e81928d (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2f04ce4-f19c-403d-8a83-74f123e5d30a (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dc998a9c-0770-111b-e053-2a95a90a88a4 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cc3656ac-3a38-a650-e053-2a95a90a912a (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f5113b5e-9087-4397-86bc-5ea10413c429 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady-state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ace2bb56-4992-49fe-9311-535b12eea9b4 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9143e0ab-0fa1-4718-919c-ddfd1e9b8386 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (V ss ) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3522bdcc-8113-4562-8ca1-f3eb884beaea (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be6d1015-306d-44fb-8d4d-01724b8d9590 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (V ss ) for sildenafil is 105L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5a14da46-a3ac-495f-bd9c-6e46d1ba6d7c (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6d8dbaa6-d61a-46ae-a641-f664104f4714 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0fa4162-e1b7-4293-ab7d-c5b375779060 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:88825206-1b91-4d95-876c-71100912d378 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:72900ed9-dbab-3f7b-e053-2a91aa0a0d24 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6d79946b-72a9-4d1b-a84b-9d1a679a82e2 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:30ce6e7f-716e-4a68-a4fb-2bb2d34ed052 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ef4d02f-76ee-4f67-9f4f-1cd554decb31 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:96ab1605-e171-4e86-b357-2d9378f7a05a (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f158fe10-d5dc-4432-b2c9-fc665401291b (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a1c3a2a2-8cf5-41c3-9c86-54290570d916 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1883785c-a1a4-48fe-b722-afacf2875ca8 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:174ef537-e3e6-42bd-a478-47b930ddc761 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fe848310-57d8-4492-829c-3e2535754a55 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:72c1516f-8a0c-495c-b11f-93bdc574ad21 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3145ceda-8c1e-4601-8a9d-5fc4978226d6 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7925711e-2e89-fd93-e053-2991aa0a507f (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f925abbe-4977-00b0-e053-6294a90a6e53 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:591a4ae7-e06c-42b6-85af-f03fd2fb8959 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c2b25818-99a3-474b-a04c-929df1110834 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (V ss ) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:71140bd5-0a51-4c01-ad0d-193d08ea67dd (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9ddfd2a-1961-90f9-e053-2a95a90a7f9b (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bb92d686-a81e-4b91-8048-693af0534cb3 (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady state volume of distribution (V ss ) for sildenafil is 105 L, indicating distribution into the tissues.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a636d3c7-af25-4148-8b4e-6f44deba700b (opens source in a new tab)
Sildenafil label
Version not recorded · Effective date not recorded
The mean steady-state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=1390Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.